Compare MEG & MPLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MEG | MPLT |
|---|---|---|
| Founded | 2012 | 2018 |
| Country | United States | United States |
| Employees | 3500 | N/A |
| Industry | Professional Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 971.5M | 811.3M |
| IPO Year | 2020 | N/A |
| Metric | MEG | MPLT |
|---|---|---|
| Price | $27.14 | $19.69 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 4 |
| Target Price | ★ $35.25 | $31.00 |
| AVG Volume (30 Days) | ★ 440.1K | 132.4K |
| Earning Date | 05-28-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 93.69 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $830,538,000.00 | N/A |
| Revenue This Year | $4.94 | N/A |
| Revenue Next Year | $7.71 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 19.26 | N/A |
| 52 Week Low | $10.51 | $12.24 |
| 52 Week High | $32.00 | $21.55 |
| Indicator | MEG | MPLT |
|---|---|---|
| Relative Strength Index (RSI) | 60.75 | 65.27 |
| Support Level | $26.93 | $16.17 |
| Resistance Level | $30.44 | $20.20 |
| Average True Range (ATR) | 1.41 | 1.19 |
| MACD | 0.35 | 0.17 |
| Stochastic Oscillator | 68.89 | 77.28 |
Montrose Environmental Group Inc is an environmental services company. The firm's operating segments are Assessment, Permitting and Response, Measurement and Analysis, and Remediation and Reuse. Through its Assessment, Permitting, and Response segment, the company provides scientific advisory and consulting services to support environmental assessments, environmental emergency response, and environmental audits. Measurement and Analysis include test and analysis of air, water, and soil to determine concentrations of contaminants whereas, the Remediation and Reuse segment provide clients with engineering, design, implementation, operations and maintenance services, to treat contaminated water, remove contaminant or create biogas. United States Contributes the majority of geographic revenue.
MapLight Therapeutics Inc is a biopharmaceutical company. The company is focused on improving the lives of patients suffering from debilitating central nervous system, or CNS, disorders. The company is engaged in psychiatry and neuroscience research to address the lack of circuit-specific pharmacotherapies available for patients. The product candidates of the company include ML-007C-MA, ML-004, ML-021, ML-009, and other pipeline products.